Last Updated on June 22, 2023

Recent Advances in Anti-Infective Drug Discovery- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.30

SJR

 0.277

h-Index

 35

Rank

 15938

Important Details

Title Recent Advances in Anti-Infective Drug Discovery
Type of Publication Journal
Discipline Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3)
Impact Score 1.30
SCImago Journal Rank (SJR) 0.277
h-index 35
Overall Rank 15938
Publisher Name Bentham Science Publishers
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 27724352, 27724344
Coverage and History 2021-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
82

About Recent Advances in Anti-Infective Drug Discovery


Recent Advances in Anti-Infective Drug Discovery is a journal published by Bentham Science Publishers. This journal covers the area[s] related to Drug Discovery, Infectious Diseases, Pharmacology (medical), etc. The coverage history of this journal is as follows: 2021-2022. The rank of this journal is 15938. This journal's impact score, h-index, and SJR are 1.30, 35, and 0.277, respectively. The ISSN of this journal is/are as follows: 27724352, 27724344.

The best quartile of Recent Advances in Anti-Infective Drug Discovery is Q3. This journal has received a total of 82 citations during the last three years (Preceding 2022).


Recent Advances in Anti-Infective Drug Discovery Impact Score 2022-2023


The latest impact score (IS) of the Recent Advances in Anti-Infective Drug Discovery is 1.30. It is computed in the year 2023 as per its definition and based on Scopus data. 1.30

It is decreased by a factor of around 0.1, and the percentage change is -7.14% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Recent Advances in Anti-Infective Drug Discovery Impact Score 2023


Impact Score 2022 of Recent Advances in Anti-Infective Drug Discovery is 1.30. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Recent Advances in Anti-Infective Drug Discovery. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.30
2021 1.40
2020 1.88
2019 0.97
2018 0.96
2017 1.26
2016 1.25
2015 2.15
2014 2.00

Recent Advances in Anti-Infective Drug Discovery h-index


  Table Setting

The h-index of Recent Advances in Anti-Infective Drug Discovery is 35. By definition of the h-index, this journal has at least 35 published articles with more than 35 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Recent Advances in Anti-Infective Drug Discovery ISSN


The International Standard Serial Number (ISSN) of Recent Advances in Anti-Infective Drug Discovery is/are as follows: 27724352, 27724344.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Recent Advances in Anti-Infective Drug Discovery Ranking and SCImago Journal Rank (SJR)


The Recent Advances in Anti-Infective Drug Discovery is ranked 15938 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.277.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Recent Advances in Anti-Infective Drug Discovery Publisher


Table Setting

The publisher of Recent Advances in Anti-Infective Drug Discovery is Bentham Science Publishers. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2021-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


How to publish in Recent Advances in Anti-Infective Drug Discovery


If your area of research or discipline is related to Drug Discovery, Infectious Diseases, Pharmacology (medical), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Recent Advances in Anti-Infective Drug Discovery?

The latest impact score of Recent Advances in Anti-Infective Drug Discovery is 1.30. It is computed in the year 2023.


What is the h-index of Recent Advances in Anti-Infective Drug Discovery?

The latest h-index of Recent Advances in Anti-Infective Drug Discovery is 35. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Recent Advances in Anti-Infective Drug Discovery?

The latest SCImago Journal Rank (SJR) of Recent Advances in Anti-Infective Drug Discovery is 0.277. It is calculated in the year 2023.


What is the ranking of Recent Advances in Anti-Infective Drug Discovery?

The latest ranking of Recent Advances in Anti-Infective Drug Discovery is 15938. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Recent Advances in Anti-Infective Drug Discovery?

Recent Advances in Anti-Infective Drug Discovery is published by Bentham Science Publishers. The publication country of this journal is United Arab Emirates.


What is the abbreviation of Recent Advances in Anti-Infective Drug Discovery?

This standard abbreviation of Recent Advances in Anti-Infective Drug Discovery is .


Is "Recent Advances in Anti-Infective Drug Discovery" a Journal, Conference or Book Series?

Recent Advances in Anti-Infective Drug Discovery is a journal published by Bentham Science Publishers.


What is the scope of Recent Advances in Anti-Infective Drug Discovery?

The scope of Recent Advances in Anti-Infective Drug Discovery is as follows:

  • Drug Discovery
  • Infectious Diseases
  • Pharmacology (medical)

For detailed scope of Recent Advances in Anti-Infective Drug Discovery, check the official website of this journal.


What is the ISSN of Recent Advances in Anti-Infective Drug Discovery?

The International Standard Serial Number (ISSN) of Recent Advances in Anti-Infective Drug Discovery is/are as follows: 27724352, 27724344.


What is the best quartile for Recent Advances in Anti-Infective Drug Discovery?

The best quartile for Recent Advances in Anti-Infective Drug Discovery is Q3.


What is the coverage history of Recent Advances in Anti-Infective Drug Discovery?

The coverage history of Recent Advances in Anti-Infective Drug Discovery is as follows 2021-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Business Economics and Management Journal Vilnius Gediminas Technical University 10343 45 2.81
CESifo Economic Studies Journal Oxford University Press 14012 32 1.70
Business Strategy Review Journal Wiley-Blackwell Publishing Ltd 31512 33 0.04
International Journal of Mathematical Education in Science and Technology Journal Taylor and Francis Ltd. 10040 39 1.33
International Journal of Applied Linguistics Journal Wiley-Blackwell Publishing Ltd 7321 51 2.00
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
Journal of Immigrant and Refugee Studies Journal Routledge 9246 32 1.46
HOMO- Journal of Comparative Human Biology Journal Elsevier BV 19810 35 0.56
WSEAS Transactions on Environment and Development Journal World Scientific and Engineering Academy and Society 17731 23 1.33

Check complete list




Recent Advances in Anti-Infective Drug Discovery Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.30
2021 1.40
2020 1.88
2019 0.97
2018 0.96
2017 1.26
2016 1.25
2015 2.15
2014 2.00



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Infectious Diseases

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Lancet Microbe, The
Elsevier Ltd. | United Kingdom

Lancet Infectious Diseases, The
Lancet Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Drug Resistance Updates
Churchill Livingstone | United States

Clinical Infectious Diseases
Oxford University Press | United Kingdom

Lancet HIV,The
Elsevier Ltd. | United Kingdom

Journal of Infection
W.B. Saunders Ltd | United Kingdom

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

Clinical Microbiology and Infection
Elsevier Ltd. | United Kingdom

Cellular and Molecular Immunology
Nature Publishing Group | United Kingdom

Trends in Microbiology
Elsevier Ltd. | United Kingdom

FEMS Microbiology Reviews
Oxford University Press | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All